Calidi Biotherapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $5.8M | $9.6M | $2.2M | $590.0K | $1.1M |
| Accounts Receivable | — | — | — | $870 | $0 |
| Inventory | — | — | — | — | — |
| Total Current Assets | $6.3M | $10.2M | $4.3M | $786.0K | $1.5M |
| Property, Plant & Equipment | $781.0K | $869.0K | $1.3M | $887.0K | — |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $8.9M | $14.2M | $10.0M | $2.6M | $231.8M |
| Liabilities | |||||
| Accounts Payable | — | — | — | $51.1K | $63.8K |
| Total Current Liabilities | $3.9M | $9.5M | $10.2M | $43.0M | $411.0K |
| Long-Term Debt | $600.0K | $600.0K | $2.1M | — | — |
| Total Liabilities | $5.1M | $12.2M | $18.3M | $43.4M | $16.5M |
| Stockholders' Equity | |||||
| Retained Earnings | $-141.6M | $-121.7M | $-99.6M | $-70.4M | $-14.7M |
| Total Stockholders' Equity | $3.8M | $1.5M | $-8.2M | $-50.4M | $-31.6M |